Pfizer to acquire Hospira for $17B

Hospira Inc. (NYSE:HSP) gained $22.84 (35%) to $87.64 on news that Pfizer Inc. (NYSE:PFE) will acquire the company for $17 billion, including the assumption of debt. The cash offer of $90 per share represents a 39% premium to Hospira's close of $64.80 on Wednesday.

Read the full 443 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE